Allworth Financial’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
AVM
Allworth Financial's BEAM Position: Q2 2026 in Review
Allworth Financial increased its Beam Therapeutics (BEAM) stake by 0.59% in Q2 2026, buying an estimated $453 and bringing the position to 2,551 shares worth $87.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2041.
Allworth Financial first reported a position in BEAM in Q3 2020 and has held it in 24 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.
- Allworth Financial held 2,551 shares of Beam Therapeutics worth $87.6K as of Q2 2026.
- Allworth Financial bought 15 Beam Therapeutics shares in Q2 2026, an estimated $453.
- Beam Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2041 holding.
- Allworth Financial first reported a position in Beam Therapeutics in Q3 2020 and has held it in 24 quarters since.
- 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.
Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.